Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) rose sharply in today's pre-market trading after the company announced results from its ongoing clinical trial of NX-5948 in patients with relapsed refractory chronic lymphocytic leukemia.

Nurix Therapeutics shares jumped 12.1% to $17.01 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

• Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) rose 89.4% to $6.61 in pre-market trading after surging 24% on Friday. Scinai Immunotherapeutics, last week, received a non-binding Letter of Intent from the European Investment Bank for converting loan into equity.
• Interactive Strength Inc. (NASDAQ:TRNR) shares rose 76.6% to $5.05 in pre-market trading after dipping 19% on Friday.
• ENDRA Life Sciences Inc. (NASDAQ:NDRA) gained 36.4% to $0.1414 in pre-market trading after a 13G filing showed a 9.99% passive stake from S.H.N. Financial Investments Ltd.
• The Aaron’s Company, Inc. (NYSE:AAN) gained 32.1% to $9.96 in pre-market trading after the company announced that it entered into a definitive agreement to be acquired by IQVentures Holdings.
• Venus Concept Inc. (NASDAQ:VERO) gained 26.1% to $1.18 in pre-market trading after the company announced that it has entered a new strategic resurfacing and skin tightening device supply arrangement with Skin Laundry Holdings.
• SRIVARU Holding Limited (NASDAQ:SVMH) shares gained 16.4% to $0.2649 in pre-market trading. SRIVARU shares jumped 49% on Friday after the company announced it will begin accepting paid reservations and bookings for its flagship product, the PRANA 2.0, on June 16th.
• Kineta, Inc. (NASDAQ:KA) rose 15.4% to $0.5990 in pre-market trading after gaining around 10% on Friday.
• IceCure Medical Ltd (NASDAQ:ICCM) shares rose 14% to $0.93 in pre-market trading after gaining around 8% on Friday.
• XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) shares climbed 13.4% to $2.37 in pre-market trading after falling around 5% on Friday. XTL recently entered into definitive agreement to acquire The Social Proxy.

Losers

• Ovid Therapeutics Inc. (NASDAQ:OVID) shares fell 64.1% to $1.18 in pre-market trading after Takeda’s Skyline study in Dravet syndrome missed its primary endpoint
• Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) shares fell 33.2% to $3.98 in pre-market trading. Kaival Brands Innovations Group shares jumped 338% on Friday after the company announced a $5 million offering of 3,012,048 units at $1.66 per unit.
• iPower Inc. (NYSE:IPW) shares fell 28.7% to $2.35 in pre-market trading after the company announced a $5 million registered direct offering.
• Bluejay Diagnostics, Inc. (NASDAQ:BJDX) fell 22% to $0.3980 in pre-market trading after jumping 12% on Friday.
• Feutune Light Acquisition Corporation (NASDAQ:FLFV) shares fell 17.8% to $8.06 in pre-market trading.
• BIMI Holdings Inc. (NASDAQ:BIMI) shares fell 15.6% to $1.86 in pre-market trading after gaining 23% on Friday.
• La Rosa Holdings Corp. (NASDAQ:LRHC) shares declined 12.8% to $1.02 in pre-market trading. La Rosa Holdings shares jumped around 76% on Friday after the company filed a request for the withdrawal of its registration statement on a Form S-1.
• Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) shares dipped 12% to $1.91 in pre-market trading after dipping over 10% on Friday.
• AMC Networks Inc. (NASDAQ:AMCX) fell 9.4% to $14.24 in pre-market trading after the company announced a private offering of $125 million of convertible senior notes.
• Evotec SE (NYSE:EVO) shares declined 7.7% to $4.20 in pre-market trading.

Now Read This: Investor Optimism Continues To Wane Despite Nasdaq’s Fifth Consecutive Record Close On Friday